# GSK plc (GSK): stock price, chart, support and resistance levels

> Source: IndicatorStack, https://indicatorstack.com/chart/GSK. Updated Nov 20, 2026, 5:35 PM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

## GSK at the Nov 20, 2026 close

GSK plc (GSK) closed at $47.76 on Nov 20, 2026, little changed from the prior close of $47.82, on roughly normal volume. It finished near the low of the day.

GSK is close to its 52-week low of $45.81. It trades 3.1% below its 50-day average and 8.6% below its 200-day average. Over the past month the shares are down 6.7%. A typical day moves about 2.5% from high to low.

LiveChart’s stack bias on the 5-minute chart is bearish (weakening) and has held since Nov 20, 11:35 AM ET. Compass, which reads the higher timeframes, has 0 of 5 timeframes up and 5 down.

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions.

## Key numbers

|  |  |
| --- | --- |
| Previous close | $47.82 |
| Open | $48.21 |
| Day range | $47.70 to $48.74 |
| 52-week range | $45.81 to $61.70 |
| Volume | 2.74M (0.8× average) |
| 50-day average | $49.31 |
| 200-day average | $52.25 |
| Average daily range | 2.5% |
| Average volume (20 days) | 3.65M |
| 1-week change | −5.3% |
| 1-month change | −6.7% |
| 3-month change | −7.8% |
| Market cap | $101B |
| Float | 1.94B shares |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |

## GSK support and resistance levels

For the next session, measured from the Nov 20, 2026 close of $47.76: resistance above, support below, nearest first.

| Side | Level | Price | From the close |
| --- | --- | --- | --- |
| Resistance | 20-bar high, 5-minute | $48.13 | +0.8% |
| Resistance | Midpoint on Nov 20 | $48.22 | +1.0% |
| Resistance | Prior session high | $48.44 | +1.4% |
| Resistance | High on Nov 20 | $48.74 | +2.1% |
| Resistance | 50-day average | $49.31 | +3.2% |
| Resistance | 20-day average | $49.85 | +4.4% |
| Resistance | 200-day average | $52.25 | +9.4% |
| Resistance | 52-week high | $61.70 | +29.2% |
| Support | Low on Nov 20 | $47.70 | −0.1% |
| Support | 52-week low | $45.81 | −4.1% |

## GSK technical analysis: the stack’s read

As of Nov 20, 2026, 5:35 PM ET.

- Stack bias: Bearish (weakening, since Nov 20, 11:35 AM ET)
  - Bigger picture (15m to daily): down
  - VWAP and SMA: down
  - Flow: down
  - Momentum: down
  - Trend strength: up
- Compass (higher timeframes): Tailwind down (15m ↘  1h ↘  2h ↘  4h ↘  D ↘). Below VWAP 48.11 · below trend SMA · inside yesterday’s range
- Yesterday’s high: $48.44 (+1.4% from the close)
- Yesterday’s midpoint: $48.06 (+0.6% from the close)
- Yesterday’s low: $47.68 (−0.2% from the close)
- 20-bar resistance: $48.13 (+0.8% from the close)
- 20-bar support: $47.68 (−0.2% from the close)

GSK technical analysis for Nov 20, 2026 (close $47.76; 5-minute read as of 5:35 PM ET): LiveChart’s 5-minute stack bias is bearish (weakening), Compass reads “Tailwind down” across the 15-minute to daily charts, and the daily stack bias has no clear direction. On the daily chart, RSI (14) is 38.6, falling (below 50) and the squeeze is off. On the 5-minute chart, Undertow reads selling drying up: price lower, flow higher; Coil reads stretched: price lower, RSI higher; Tripwire has shorts graded Caution: volume fading into the entry.

## GSK trend by timeframe

| Timeframe | Direction |
| --- | --- |
| 15-minute | Leaning down |
| 1-hour | Leaning down |
| 2-hour | Leaning down |
| 4-hour | Leaning down |
| Daily | Leaning down |

## GSK order flow, momentum and trap risk

LiveChart’s Undertow, Coil and Tripwire on the 5-minute chart as of 5:35 PM ET, then the same three on the daily chart at the close.

- **Undertow (order flow)**: Selling drying up: price lower, flow higher
  - Volume: 0x this session’s norm · thin, size down
  - Flow: Price lower, volume flow higher
  - Tape: No large orders or stacking
- **Coil (momentum)**: Stretched: price lower, RSI higher
  - Momentum: RSI 52 above 50, turning up · no squeeze
  - MACD: Below its signal, fading
- **Tripwire (trap risk)**: Shorts graded Caution: volume fading into the entry
  - Longs graded Caution: volume fading into the entry
  - Levels: Resistance 48.13 · support 47.68
- **Undertow, daily chart**: Hidden buying: price lower, flow higher
- **Coil, daily chart**: Momentum building down
- **Tripwire, daily chart**: Longs graded Avoid: support looks fake, heavy tape on it

## GSK technical indicators

Daily readings at the Nov 20, 2026 close; 5-minute readings as of 5:35 PM ET.

| Indicator | Value | Reading |
| --- | --- | --- |
| RSI (14), daily | 38.6 | Below 50, falling |
| RSI (14), 5-minute | 51.9 | Above 50, rising |
| Squeeze, daily | Off | Bollinger Bands outside the Keltner Channel |
| Squeeze, 5-minute | Off | Bollinger Bands outside the Keltner Channel |
| MACD, daily | Below its signal |  |
| MACD, 5-minute | Below its signal |  |
| VWAP, last 5-minute bar | $48.11 | Price 0.3% below |
| Fast and slow EMA, 5-minute | $47.82 and $47.89 | Fast under slow |
| 20-day average | $49.85 | Price 4.2% below |
| 50-day average | $49.31 | Price 3.1% below |
| 200-day average | $52.25 | Price 8.6% below |
| Average daily range (ATR 14) | 2.5% | Of the price |
| Volume against its 20-day average | 0.8× | 2.74M shares |

## GSK trend history: when the daily bias turned

| Turned | Bias | Price | Held | Move while it held |
| --- | --- | --- | --- | --- |
| Oct 26, 2026 | No clear bias | $51.10 | Holding, 20 sessions | −6.5% |
| Oct 2, 2026 | Bearish | $47.03 | 16 sessions | +8.7% |
| Jun 30, 2026 | No clear bias | $52.42 | 66 sessions | −10.3% |
| May 1, 2026 | Bearish | $51.61 | 40 sessions | +1.6% |
| Apr 2, 2026 | No clear bias | $56.69 | 20 sessions | −9.0% |
| Mar 17, 2026 | Bearish | $53.41 | 12 sessions | +6.1% |
| Mar 16, 2026 | No clear bias | $53.77 | 1 sessions | −0.7% |
| Feb 6, 2026 | Bullish | $60.23 | 25 sessions | −10.7% |
| Jan 21, 2026 | No clear bias | $48.07 | 12 sessions | +25.3% |
| Sep 10, 2025 | Bullish | $40.50 | 91 sessions | +18.7% |
| Aug 18, 2025 | No clear bias | $39.07 | 16 sessions | +3.7% |
| Jul 16, 2025 | Bearish | $38.28 | 23 sessions | +2.1% |

Past readings don’t predict future results.

## GSK daily read log

| Date | Close | Change | Stack bias | Compass | Daily RSI |
| --- | --- | --- | --- | --- | --- |
| Nov 20, 2026 | $47.76 | −0.13% | Bearish | Tailwind down | 38.6 |
| Nov 16, 2026 | $50.41 | −0.08% | Bearish | Higher timeframes still up | – |

## GSK stock: common questions

### What are GSK’s support and resistance levels?

Measured from the Nov 20, 2026 close of $47.76, the nearest resistance is the 20-bar high, 5-minute at $48.13 (+0.8%) and the nearest support is the low on Nov 20 at $47.70 (−0.1%). The full list for the next session is on this page.

### What is the technical analysis for GSK?

GSK technical analysis for Nov 20, 2026 (close $47.76; 5-minute read as of 5:35 PM ET): LiveChart’s 5-minute stack bias is bearish (weakening), Compass reads “Tailwind down” across the 15-minute to daily charts, and the daily stack bias has no clear direction. On the daily chart, RSI (14) is 38.6, falling (below 50) and the squeeze is off. On the 5-minute chart, Undertow reads selling drying up: price lower, flow higher; Coil reads stretched: price lower, RSI higher; Tripwire has shorts graded Caution: volume fading into the entry.

### Is GSK overbought or oversold?

At the Nov 20, 2026 close, GSK’s daily RSI (14) was 38.6, falling (below 50). On the 5-minute chart, as of 5:35 PM ET, it was 51.9, rising (above 50). Overbought here means 70 or over, oversold 30 or under; neither forecasts a turn.

### What is the trend for GSK on the 1-hour, 4-hour and daily charts?

As Compass read it at the Nov 20, 2026 close: 15-minute leaning down, 1-hour leaning down, 2-hour leaning down, 4-hour leaning down, Daily leaning down. Overall, Compass reads “Tailwind down”.

### Is GSK in a squeeze?

At the Nov 20, 2026 close the squeeze (Bollinger Bands inside the Keltner Channel) was off on the daily chart and off on the 5-minute chart (as of 5:35 PM ET). Coil, LiveChart’s momentum layer, boxes every squeeze on the chart and marks its release.

### Are buyers or sellers in control of GSK?

As of 5:35 PM ET on Nov 20, 2026, Undertow, LiveChart’s order flow layer, read selling drying up: price lower, flow higher on the 5-minute chart (volume: 0x this session’s norm · thin, size down; flow: Price lower, volume flow higher; tape: No large orders or stacking).

### Is GSK at risk of a bull or bear trap?

As of 5:35 PM ET on Nov 20, 2026, Tripwire, LiveChart’s trap check, had shorts graded Caution: volume fading into the entry on the 5-minute chart; longs graded Caution: volume fading into the entry; levels: Resistance 48.13 · support 47.68. Its grades describe the structure around price; they aren’t a call on direction.

### What is GSK plc’s stock price?

GSK closed at $47.76 on Nov 20, 2026, −0.13% on the day. The chart at the top of this page shows the latest price while the market is open.

### Is GSK bullish or bearish right now?

As of the Nov 20, 2026 close the stack bias is bearish (weakening), with 1 of its 5 reads pointing up. On the daily chart it is no clear bias. Compass reads “Tailwind down” across the 15-minute to daily timeframes. This describes the trend at the last close; it isn’t a forecast.

### Is GSK above its 50-day and 200-day moving averages?

At the Nov 20, 2026 close of $47.76, GSK was 3.1% below its 50-day moving average ($49.31) and 8.6% below its 200-day moving average ($52.25).

### What is GSK’s 52-week high and low?

Over the past year GSK has traded between $45.81 and $61.70, and it closed 12% of the way up that range.

### How much does GSK move in a day?

Over the last 14 sessions its average daily range (average true range) was 2.5% of its price, about $1.19 a share.

### What is GSK’s average volume?

GSK averaged 3.65M shares a day over the 20 sessions before Nov 20, 2026. That day it traded 2.74M, 0.8 times that average.

### How has GSK stock performed recently?

Measured to the Nov 20, 2026 close, GSK is down 5.3% over the past week, down 6.7% over the past month and down 7.8% over the past three months.

### How many shares of GSK are in the float?

About 1.94B shares.

### What is GSK plc’s market cap?

About $101B, from its latest company profile. It is in the Healthcare sector (Drug Manufacturers - General).

### What is the outlook for GSK stock?

This page doesn’t forecast prices. It shows where GSK stands: the stack bias is bearish, the nearest resistance is $48.13, the nearest support is $47.70, and the live chart above shows how price is reacting to those levels.

## Other Healthcare stocks

- MEDS (+84.1%): https://indicatorstack.com/chart/MEDS
- ACH (−76.7%): https://indicatorstack.com/chart/ACH
- APRE (−53.6%): https://indicatorstack.com/chart/APRE
- SNTI (−36.6%): https://indicatorstack.com/chart/SNTI
- SPRC (−34.8%): https://indicatorstack.com/chart/SPRC
- PMVP (−33.1%): https://indicatorstack.com/chart/PMVP
- JAGX (−30.6%): https://indicatorstack.com/chart/JAGX
- VRAX (−26.9%): https://indicatorstack.com/chart/VRAX
- IBO (+25.7%): https://indicatorstack.com/chart/IBO
- AKAN (+23.3%): https://indicatorstack.com/chart/AKAN

Live chart with the stack’s read on every bar: https://indicatorstack.com/chart/GSK

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
